Novartis Inc header image

Novartis Inc

NOVN

Equity

ISIN CH0012005267 / Valor 1200526

SIX Swiss Exchange (2026-06-25)
CHF 126.00+1.34%

Novartis Inc
UMushroom community rating:

star star star star star
3.95 45 votes No rating yet
NegativeNeutralPositive

About company

Novartis Inc. is a global healthcare company that specializes in the development and distribution of innovative medicines. With a focus on addressing unmet medical needs, Novartis aims to improve and extend the lives of people suffering from serious diseases. The company operates in several core therapeutic areas, including cardiovascular, renal and metabolic diseases, immunology, neuroscience, and oncology. Novartis is known for its commitment to research and development, leveraging advanced technology platforms to create groundbreaking therapies. With a workforce of approximately 78,000 employees representing over 140 nationalities, Novartis has a significant global presence, reaching more than 284 million patients worldwide. The company's strategy revolves around delivering high-value medicines and employing novel access approaches to alleviate some of society's most significant disease burdens.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

32.6%1Y
46.6%3Y
57.0%5Y

Performance

19.2%1Y
18.9%3Y
18.3%5Y

Volatility

Market cap

297284 M

Market cap (USD)

Daily traded volume (Shares)

2,913,400

Daily traded volume (Shares)

1 day high/low

88.82 / 87.81

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.95

45 votes
Performance:
starstarstarstarstar
3.61
Innovation:
starstarstarstarstar
3.95
Society:
starstarstarstarstar
3.89
Nature:
starstarstarstarstar
3.45
Oliver Frei
Switzerland, 21 Mar 2026
star star star star star
-
Pavle Stojicic
Switzerland, 20 Mar 2026
star star star star star
Great company, wrong year to expect excitement. Own it in 2027 when the patent cliff is behind them and the new drugs are fully ramping.
Lorenzo Castillejo
Switzerland, 19 Mar 2026
star star star star star
Amazing stock

EQUITIES OF THE SAME SECTOR

Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 24.73
Corcept Therapeutics Inc
Corcept Therapeutics Inc Corcept Therapeutics Inc Valor: 1812837
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.91%USD 84.75
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.40%USD 415.53
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 69.69
GSK PLC
GSK PLC GSK PLC Valor: 120042705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.57%USD 51.89
Interparfums
Interparfums Interparfums Valor: 86977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%EUR 25.45
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
19.68%CHF 2.21
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.97%CHF 12.61
LivaNova PLC
LivaNova PLC LivaNova PLC Valor: 28726218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.38%USD 81.05
Attendo AB
Attendo AB Attendo AB Valor: 30491576
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%SEK 120.80